Breast cancer screening guidelines: discrepancies raise concerns about validity Nikita JhangianiMegha PhilipIsmail Jatoi Opinion 14 August 2023 Pages: 869 - 871
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2022 edition Mitsuo TeradaAki ItoTatsuya Toyama Special Article Open access 07 October 2023 Pages: 872 - 884
Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review Orellana-Jaén JesúsCarrasco-Páez LuisMora-Fernández Matilde Review Article Open access 22 July 2023 Pages: 885 - 909
MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis R. L. AkshayaI. SaranyaN. Selvamurugan Review Article 14 August 2023 Pages: 910 - 925
Self-help management of patients undergoing chemotherapy: analysis of the online forum of the women’s self-help association against cancer C. ColditzC. KeinkiJ. Huebner Original Article Open access 07 July 2023 Pages: 926 - 932
Significance of skeletal muscle index-to-body mass index ratio as a predictor of post-surgical bleeding after mastectomy in patients with breast cancer Hiroki MorikawaTakaaki ObaKen-ichi Ito Original Article 13 July 2023 Pages: 933 - 942
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316) Manabu FutamuraTakahiro NakayamaNorikazu Masuda Original Article Open access 24 July 2023 Pages: 943 - 951
Factors associated with non-participation in breast cancer screening: analysis of the 2016 and 2019 comprehensive survey of living conditions in Japan Chitose KawamuraMasao IwagamiNanako Tamiya Original Article 25 July 2023 Pages: 952 - 964
Prognosis difference between HER2-low and HER2-zero breast cancer patients: a systematic review and meta-analysis Chengxin LiQianqian YuanGaosong Wu Original Article 20 July 2023 Pages: 965 - 975
Diagnostic accuracy of pre-operative breast magnetic resonance imaging (MRI) in predicting axillary lymph node metastasis: variations in intrinsic subtypes, and strategy to improve negative predictive value—an analysis of 2473 invasive breast cancer patients Shu-Tian ChenHung-Wen LaiChe-Lun Hung Original Article Open access 27 July 2023 Pages: 976 - 985
Prognosis of post-neoadjuvant therapy patients who underwent immediate breast reconstruction: a SEER-based, propensity-matched study Jiahao PanLiying PengJian Zhang Original Article Open access 28 July 2023 Pages: 986 - 996
Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy Silvia Mihaela IlieNathalie BriotSylvain Ladoire Original Article Open access 10 August 2023 Pages: 997 - 1007
Evaluation of quality of life in breast cancer patients who underwent breast-conserving surgery or mastectomy using real-world data Shiao Li OeiAnja ThronickeJessica Groß Original Article 16 August 2023 Pages: 1008 - 1017
Ex vivo dual gene therapy using human adipocytes secreting anti-HER2 antibody on HER2-positive xenograft tumor models Ryotaro TeranakaHiroshi FujimotoMasayuki Ohtsuka Original Article 23 August 2023 Pages: 1018 - 1027
Breast cancer-derived exosomal lncRNA SNHG14 induces normal fibroblast activation to cancer-associated fibroblasts via the EBF1/FAM171A1 axis Huaying DongChangcheng YangWei Wang Original Article 31 August 2023 Pages: 1028 - 1040
Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes Fumiaki SanukiYuka MikamiTakuya Moriya Original Article 29 August 2023 Pages: 1041 - 1053
Assessment of nuclear grade-based recurrence risk classification in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, node-positive high-risk early breast cancer Takeshi MurataMasayuki YoshidaAkihiko Suto Original Article Open access 23 August 2023 Pages: 1054 - 1064
Preparation, characterization, and in vitro cytotoxicity activity of allyl-isothiocyanate-embedded polymeric nanoparticles for potential breast cancer targeting Prashant Bhagwan PatilJayvadan Kantilal Patel Original Article 11 September 2023 Pages: 1065 - 1078
Glutaminase (GLS1) gene expression in primary breast cancer Neelima VidulaChristina YauHope S. Rugo Original Article 07 September 2023 Pages: 1079 - 1084
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer Hiroki KusamaNobuyoshi KittakaTakahiro Nakayama Original Article 02 October 2023 Pages: 1085 - 1093
Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer Kazushi SuzukiRintaro OheMitsuru Futakuchi Original Article Open access 04 October 2023 Pages: 1094 - 1104
Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen? Kadri Altundag Letter to the Editor 04 May 2023 Pages: 1105 - 1105
Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?” Shozo Ohsumi Letter to the Editor 21 August 2023 Pages: 1106 - 1106
Is there any association between acute kidney injury and olaparib use in patients with BRCA1- or BRCA2-mutated high-risk early breast cancer from the phase 3 OlympiA trial Kadri Altundag Letter to the Editor 11 May 2023 Pages: 1107 - 1107
